Complete Up To Date Information about Gallimycin Injectable.
NADA Number: 012-123 | |
| Proprietary Name |
Gallimycin® Injectable Erythro® - 100, 200 |
|---|---|
| Sponsor |
Cross Vetpharm Group Ltd. |
| Sponsor Address |
Broomhill rd. Tallaght, Dublin, 24 IRELAND |
| Ingredients |
Erythromycin |
| Species |
Cattle, beef Cat, no use class stated or implied Cattle, dairy, not breeding age Dog, no use class stated or implied |
| Routes of Administration |
Intramuscular |
| Dose Form |
Liquid |
| Drug Form |
Liquid |
| Dispensing Status |
OTC |
| Withdrawal Time |
Cattle: 6 days before slaughter. |
|
Dosage Amount, Indications & Limitations |
522.820 Erythromycin injection. Specifications: Each milliliter of polyethylene glycol vehicle contains 100 milligrams of erythromycin base with 2 percent butyl aminobenzoate. Conditions of use: Dogs Amount: 3 to 5 milligrams per pound of body weight, intramuscularly, two to three times daily, for up to 5 days. Administer by deep intramuscular injection into the heavy muscles of the neck and limbs. Indications: For the treatment of bacterial pneumonia, upper respiratory infections (tonsillitis, bronchitis, tracheitis, pharyngitis, pleurisy), endometritis and metritis, and bacterial wound infections caused by Staphylococcus species, Streptococcus species, and Corynebacterium species, sensitive to erythromycin. Limitations: Do not administer intravenously or intraperitoneally. Avoid subcutaneous use. Do not administer from moist or wet syringe. As with all antibiotics, appropriate in vitro culturing and susceptibility testing of samples taken before treatment should be conducted. Do not administer in conjunction with penicillin. As with all antibiotics, excessive continuous use may result in an overgrowth of non- susceptible organisms. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Cats Amount: 3 to 5 milligrams per pound of body weight, intramuscularly, two to three times daily, for up to 5 days. Administer by deep intramuscular injection into the heavy muscles of the neck and limbs. Indications: For the treatment of bacterial pneumonia, upper respiratory infections (rhinitis, bronchitis), secondary infections associated with panleukopenia, and bacterial wound infections caused by Staphylococcus species and Streptococcus species, susceptible to erythromycin. Limitations: Do not administer intravenously or intraperitoneally. Avoid subcutaneous use. Do not administer from moist or wet syringe. As with all antibiotics, appropriate in vitro culturing and susceptibility testing of samples taken before treatment should be conducted. Do not administer in conjunction with penicillin. As with all antibiotics, excessive continuous use may result in an overgrowth of non-susceptible organisms. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Specifications: Each milliliter (mL) of solution contains either 100 or 200 milligrams (mg) erythromycin base. Conditions of use: Cattle Amount: 4 milligrams of erythromycin base per pound of body weight once daily for up to 5 days. For intramuscular use. Indications: For the treatment of bovine respiratory disease (shipping fever complex and bacterial pneumonia) associated with Pasteurella multocida susceptible to erythromycin. Limitations: Do not use in female dairy cattle over 20 months of age. Do not slaughter treated animals within 6 days of last treatment. A withdrawal period has not been established for this product in pre-ruminating calves. Do not use in calves to be processed for veal. To avoid excess trim, do not slaughter within 21 days of last injection. NAS/NRC status: The conditions of use have been reviewed by NAS/NRC and found effective. |
| Tolerances |
Tolerances for residues of erythromycin in food are established as follows: a. In beef cattle and swine: 0.1 part per million in uncooked edible tissues b. In milk: zero c. In uncooked eggs: 0.025 part per million d. In chickens and turkeys: 0.125 part per million (negligible residue) in uncooked edible tissues |